-
PanProstate Cancer Group DK data
Study
EGAS50000001616
-
PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach
Study
EGAS00001004692
-
Neoadjuvant immune checkpoint blockade in mismatch-repair proficient colon cancers
Study
EGAS50000000856
-
Whole-exome sequencing (WES) analysis of untreated head and neck cancer patient-derived xenografts (PDXs) matched patient tumor tissue and normal mucosa tissue.
Study
EGAS50000001622
-
EOSC4Cancer Synthetic Colorectal Cancer Genomic data
Study
EGAS50000000190
-
Gene expression profiling in pregnancy-associated breast cancer
Study
EGAS00001008013
-
Spatial transcriptomics analysis of triple negative breast cancers
Study
EGAS50000000475
-
Single cell transcriptomics to characterize the tumor microenvironment of prostate cancer fusion biopsies
Study
EGAS50000000888
-
A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow
Study
EGAS50000001529
-
A mathematical model of cell-free DNA fragment size reveals cancer-specific fragmentomic patterns
Study
EGAS50000001560
-
Delineating pediatric brain tumor progression using single-nuclei sequencing
Study
EGAS50000001288
-
Extreme intratumor heterogeneity and driver evolution in mismatch repair deficient gastro-esophageal cancer
Study
EGAS00001003434
-
A New CA19-9 Cut-Off Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC
Study
EGAS50000001575
-
B Cell Receptor Study From Early Breast Cancer Tumour Samples
Study
EGAS50000000241
-
Pediatric B-cell precursor acute lymphoblastic leukemia Micro-C sequencing
Study
EGAS50000000764
-
Comprehensive genomic characterization of early stage bladder cancer - nanopore sequencing
Study
EGAS50000000510
-
Motif-directed chromatin repression by BCL11B shapes ectopic targeting and lineage commitment
Study
EGAS50000001719
-
Monosomy 7 delineates a primitive acute myeloid leukemia with adverse prognosis and responsiveness to epigenetic therapy
Study
EGAS50000001641
-
AGECAN - Interespecies conservation of brain specific DNA methylation in aging and cancer
Study
EGAS00001004851
-
CITE-seq for peripheral blood samples of 5 breast cancer patients
Study
EGAS00001006241
-
Multi-omics analysis of an individual with multiple pancreatic neuroendocrine tumours (panNETs)
Study
EGAS00001006722
-
PDX gene expression
Study
EGAS50000000084
-
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
Study
EGAS50000001191
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
Clinical Utility of Breast cancer Research by Inocras, Catholic university hospital and Samsung medical center
Study
EGAS50000001377
-
Bulk RNASeq of metastatic colorectal cancer organoids treated with crenigacestat alone or in combination with cetuximab
Study
EGAS50000001422
-
Molecular biomarkers in progression from refractory celiac disease to the lethal cancer variety enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001006669
-
Enhanced detection of MRD with cfDNA Fragmentomics.
Study
EGAS00001007192
-
Multi Omics of glioma in the the Chinese Glioma Genome Atlas (CGGA) project
Study
EGAS00001004729
-
Mixed Histology Lung Cancers Driven by Transcriptomic Features rather than Genomic Characteristics
Study
EGAS00001005140
-
Mitochondrial DNA sequencing
Study
EGAS00001005540
-
Comprehensive genomic characterization of early stage bladder cancer - whole exome sequencing data
Study
EGAS50000000511
-
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: Primary phase 2 trial results with ctDNA residual disease analyses
Study
EGAS50000001195
-
Somatic L1 retrotransposition dynamics in high-grade serous ovarian cancer
Study
EGAS50000001198
-
Non-coding mutations drive persistence of a founder pre-leukemic clone which initiates late relapse in T-ALL
Study
EGAS50000000129
-
Preliminary Results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT 2) Study
Study
EGAS00001004964
-
Broad utility of ultrasensitive analysis of ctDNA dynamics across solid tumors treated with immunotherapy
Study
EGAS50000001333
-
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer: exploratory biomarker analyses from CheckMate 577
Study
EGAS50000001663
-
A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome
Study
EGAS00000000052
-
Genomic and transcriptomic profiling of colorectal cancer patient-derived organoids
Study
EGAS50000001669
-
Breast Cancer Follow Up Series
Study
EGAS00001000002
-
Multifocal_Breast_Project
Study
EGAS00001000004
-
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
Study
EGAS50000001368
-
Using RNA-sequencing to characterize the resistance to lirafugratinib
Study
EGAS50000001370
-
Kaposi_sarcoma_exome
Study
EGAS00001000032
-
Analysis of Multiparametric MR imaging and tumor tissue sampling to identify response and acquired resistance to HIF-2 inhibition in patients with advanced clear cell renal cell carcinoma enrolled in a phase 1, multiple-dose, dose-escalation trial of PT2385, a HIF-2alpha inhibitor
Study
EGAS00001003506
-
Immunoreactive_p53_areas_in_human_skin_2
Study
EGAS00001004463
-
Using Exome-sequencing to characterize the resistance to lirafugratinib
Study
EGAS50000001371
-
CIAO Clinical Trial
Study
EGAS50000001174
-
A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome
Study
EGAS00001000245